Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | TERT | O14746 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16552761 | 0.89 | HPGD (0.38) | KDM1ANPSR1ALDH1A1HPGDPABPC1 | |
| SCHEMBL1984060 | 0.84 | PABPC1 (0.42) | ALDH1A1PABPC1APOBEC3AEIF4HAPOBEC3G | |
| Bromide SCHEMBL14765198 | 0.83 | PABPC1 (0.41) | ALDH1A1PABPC1APOBEC3AEIF4HAPOBEC3G | |
| Hydrochloric Acid SCHEMBL14764903 | 0.83 | PABPC1 (0.46) | ALDH1A1PABPC1APOBEC3AEIF4HAPOBEC3G | |
| SCHEMBL16552862 | 0.82 | TERT (0.50) | KDM1ANPSR1ALDH1A1TERTRAB9A | |
| SCHEMBL16552577 | 0.82 | PABPC1 (0.38) | ALDH1A1PABPC1APOBEC3AEIF4HAPOBEC3G | |
| Trifluoromethanesulfonic Acid SCHEMBL3630137 | 0.68 | KCNH2 (0.47) | TERTKCNH2ACHE | |
| SCHEMBL4183399 | 0.67 | LTA4H (0.56) | KDM1ANPSR1ALDH1A1RAB9AMEN1 | |
| SCHEMBL14063445 | 0.67 | GAA (0.54) | ALDH1A1HPGDRAB9ATSHRHTT | |
| Trifluoromethanesulfonic Acid SCHEMBL30330519 | 0.66 | KCNH2 (0.45) | KCNH2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2753620-B1 | NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL | SANDOZ AG (CH) | 2017-02-15 | — | — | EP | disclosed |
| US-9382278-B2 | Process for preparing ceftaroline fosamil | SANDOZ AG (CH) | 2016-07-05 | — | — | US | disclosed |
| US-20160009745-A1 | NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL | SANDOZ AG (CH) | 2016-01-14 | — | — | US | disclosed |
| US-9169239-B2 | Process for preparing ceftaroline fosamil | SANDOZ AG (CH) | 2015-10-27 | — | — | US | disclosed |
| US-20150073138-A1 | NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL | SANDOZ AG (CH) | 2015-03-12 | — | — | US | disclosed |
| WO-2013034718-A1 | NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL | SANDOZ AG (CH) | 2013-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150073138-A1 | NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL | FOS, FOSB, CYP3A7 | KDM1A 1428/4885NPSR1 3511/4885ALDH1A1 2709/4885 |
| US-20160009745-A1 | NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL | FOS, FOSB, CYP3A7 | KDM1A 934/4885NPSR1 3546/4885ALDH1A1 1757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.